Article Information
History
- March 22, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- JQ Xie, BS.Med, MSc1,
- A Prats-Uribe, FFPH, DPhil1,
- Q Feng, PhD2,
- YH Wang, MSc2,
- D Gill, MD, PhD3,4,5,
- R Paredes, MD, PhD6 and
- D Prieto-Alhambra, MD, PhD1,*
- 1Centre for Statistics in Medicine and NIHR Biomedical Research Centre Oxford, NDORMS, University of Oxford, Oxford, United Kingdom
- 2Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
- 3Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK
- 4Department of Clinical Pharmacology and Therapeutics, Institute for Infection and Immunity, St George’s, University of London, London, UK
- 5Genetics Department, Novo Nordisk Research Centre Oxford, Old Road Campus, Oxford, UK
- 6Infectious Diseases Department & irsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Catalonia, Spain
- ↵*Correspondence to: Prof Daniel Prieto-Alhambra, Botnar Research Centre, Windmill Road, OX37LD, Oxford, UK, Daniel.prietoalhambra{at}ndorms.ox.ac.uk
Posted March 22, 2022.
Venous Thromboembolism in Ambulatory Covid-19 patients: Clinical and Genetic Determinants
